Geir O'Rourke - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Geir O'Rourke's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Geir O'Rourke

Geir O'Rourke

Verified

Political Editor, The Limbic

Sydney

Final Covers

toys behavioral issues in children,Parenting discipline, children

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 1272

  • New myelofibrosis treatment listed on PBS

    By Geir O'Rourke Verified| The Limbic Verified Momelotinib is now available on the PBS for patients with myelofibrosis who have moderate to severe anaemia. The Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing after determining the JAK inhibitor demonstrated non-inferior effectiveness and safety compared to ruxolitinib, with specific benefits for anaemia management.

    By Geir O'Rourke Verified · The Limbic

    Apr. 01, 2025

  • Is ‘rational compassion’ the answer to doctor burnout?

    By Geir O'Rourke Verified| The Limbic Verified What exactly is burnout? And what truly causes it? Despite growing awareness of the issue in healthcare, these crucial questions remain surprisingly elusive. The next step of moving beyond burnout to foster fulfilment among health professionals feels further still. The statistics will be familiar to many. Even back in 2013, 32% of Australian doctors reported emotional exhaustion in a now-infamous beyondblue survey (link here).

    By Geir O'Rourke Verified · The Limbic

    Mar. 17, 2025

  • New myelofibrosis treatment listed on PBS

    By Geir O'Rourke Verified| The Limbic Verified Momelotinib is now available on the PBS for patients with myelofibrosis who have moderate to severe anaemia. The Pharmaceutical Benefits Advisory Committee (PBAC) recommended the listing after determining the JAK inhibitor demonstrated non-inferior effectiveness and safety compared to ruxolitinib, with specific benefits for anaemia management.

    By Geir O'Rourke Verified · The Limbic

    Apr. 01, 2025

As seen in

Company Info

The Limbic

Limbic is a clinical AI company based in London, UK, founded in 2018. It focuses on providing AI-driven solutions for mental healthcare. The company has raised $14 million in Series A funding as of March 2024. Limbic offers several products, including Limbic Access, an AI chatbot designed for patient triage and referral, and Limbic Care, a generative AI companion that provides support between therapy sessions with over 100 clinically validated activities. Their clinical AI tools help reduce the administrative workload for therapists and enhance diagnostic accuracy, ultimately improving patient outcomes. Limbic collaborates with the NHS, having supported over 260,000 patients and freeing up more than 50,000 clinical hours. The company emphasizes inclusivity, particularly for LGBTQ+ and non-binary patients, and aims to improve efficiency in behavioral health services.

Sydney, Australia